-
Most Popular
Earnings Reports
DC Stock Earnings: Dakota Gold Reported Results for Q2 2024
Dakota Gold just reported results for the second quarter of 2024.
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024.
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q2 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
SYPR Stock Earnings: Sypris Solutions Reported Results for Q2 2024
Sypris Solutions just reported results for the second quarter of 2024.
OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q2 2024
OVID stock results show that Ovid Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
MSC Stock Earnings: Studio City Intl Hldgs Reported Results for Q2 2024
Studio City Intl Hldgs just reported results for the second quarter of 2024.
CING Stock Earnings: Cingulate Misses EPS for Q2 2024
CING stock results show that Cingulate missed analyst estimates for earnings per share the second quarter of 2024.
JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q2 2024
JAGX stock results show that Jaguar Health missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q2 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the second quarter of 2024.
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024
ACRV stock results show that Acrivon Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
EVOK Stock Earnings: Evoke Pharma Misses EPS, Misses Revenue for Q2 2024
EVOK stock results show that Evoke Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q2 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024
Candel Therapeutics just reported results for the second quarter of 2024.
CSCI Stock Earnings: AEterna Zentaris Beats Revenue for Q2 2024
CSCI stock results show that AEterna Zentaris beat on revenue for the second quarter of 2024.
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q2 2024
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the second quarter of 2024.
STI Stock Earnings: Solidion Technology Reported Results for Q2 2024
Solidion Technology just reported results for the second quarter of 2024.
GRNQ Stock Earnings: Greenpro Capital Reported Results for Q2 2024
Greenpro Capital just reported results for the second quarter of 2024.
